Silverarc Capital Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Silverarc Capital Management’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,000	Closed	-$7.01K	–	106
2023 Q2	$7.01K	Hold	10,000	–	–	﹤0.01%	82
2023 Q1	$6.6K	Hold	10,000	–	–	﹤0.01%	72
2022 Q4	$15K	Buy	+10,000	New	+$17.7K	0.01%	89

Other funds holding FRTX

JBF Capital Aspen, Colorado $674M AUM 24.74% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return